Abstract-Recent studies in hypertensive populations that have used the serum aldosterone (SA) to plasma renin activity (PRA) ratio as a screening test have demonstrated a high prevalence of primary aldosteronism (PA). This frequency is higher than that previously described when hypokalemia was used as a screening tool. However, other factors, such as the characteristics of hypertensive disease, could also influence the prevalence of PA. We studied 609 essential hypertensive patients, classified according to the Joint National Committee VI (JNC VI), in 3 different stages depending on the severity of their hypertensive disease. We measured SA and PRA and calculated the SA-PRA ratio for all patients. An SA-PRA ratio Ͼ25
One hundred seventy-three Escherichia coli strains isolated from calves from northwestern São Paulo State, having diarrhea were examined for the production of thermolabile (LT) and thermostable (ST) enterotoxins and for the presence of virulence factors associated with bovine colibacillosis. Eighty-five (49.1%) of the E.coli strains produced toxins; 53 isolates were detected as producing STa toxin, and 9 also produced LT toxin. By PCR, 23 isolates were shown to harbor only the LT-II gene. Nine (5.2%) isolates harbored Shiga toxin genes: four carried the stx2 gene, four the stx1 gene and one carried both. Three of the isolates showing stx1 also carried the eae gene. Among the E. coli isolates examined for susceptibility to 10 antimicrobial agents, resistance to cephalothin (46.1%), was most commonly observed, followed by resistances to tetracycline (45.7%), trimethoprim-sulfadiazine (43.3%) and ampicilin (41.0%). All isolates showed resistance to at least two antimicrobial agents; multidrug resistance was quite frequently encountered. Results showed that bovine E. coli produces some toxins and virulence factors, some of which may be involved in human disease. The isolates showed a high level of resistance to antimicrobial agents constituting a public health concern.Keywords: calf, diarrhea, Escherichia coli, virulence factor, antimicrobial agent
RESUMO
Cento e setenta e três cepas de Escherichia coli isoladas de bezerros com diarréia provenientes da região noroeste do estado de São Paulo foram examinadas para a produção de enterotoxinas termolábil (LT) e termoestável (ST), e examinadas quanto à presença de fatores de virulência associados a colibacilose bovina. Oitenta e cinco (49,1%) das cepas de E. coli produziram toxinas, 53 cepas foram detectadas como produtoras de toxina STa, e nove dessas cepas também produziam toxina LT. Foram identificadas pela reação em cadeia de polimerase 23 cepas portadoras do gene LT-II. Nove (5,2%) das cepas apresentavam os genes de toxina
The purposes of this study were to detect S. mutans and S. sobrinus by polymerase chain reaction (PCR) amplification, and to relate their presence to the incidence of dental caries in 42 Brazilian preschool children. Dental plaque samples were collected from the cervical margin of all erupted teeth of 5-6 years old children with primary dentition, using a sterile explorer. Examination of the dmft (decayed, missing, filled teeth) index, performed following the World Health Organization (WHO) caries diagnostic criteria, showed a 2.71 score. Prevalence of S. mutans and S. sobrinus was respectively, of 85.7% and 14.3%; no dental plaque sample was either positive or negative for both bacterial species. Children harboring either S. mutans or S. sobrinus presented the same caries prevalence. PCR showed good discriminative ability for differentiation between these species, and suggested that it is a technique suitable for epidemiological studies on mutans streptococci.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.